Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.

@article{Lowder2011DexamethasoneII,
  title={Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.},
  author={C Lowder and Rubens Belfort and Sue Lightman and Charles Stephen Foster and Michael R Robinson and Rhett M Schiffman and Xiao-yan Li and Harry Cui and Scott M. Whitcup},
  journal={Archives of ophthalmology},
  year={2011},
  volume={129 5},
  pages={545-53}
}
OBJECTIVE To evaluate the safety and efficacy of 2 doses of dexamethasone intravitreal implant (DEX implant) for treatment of noninfectious intermediate or posterior uveitis. METHODS In this 26-week trial, eyes with noninfectious intermediate or posterior uveitis were randomized to a single treatment with a 0.7-mg DEX implant (n = 77), 0.35-mg DEX implant (n = 76), or sham procedure (n = 76). MAIN OUTCOME MEASURE The main outcome measure was the proportion of eyes with a vitreous haze score… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 155 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Uveitis, evaluation and treatment

  • RH Janigian, D. Young
  • http://emedicine .medscape.com/article/1209123…
  • 2010
Highly Influential
4 Excerpts

The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema

  • B van Kooij, A Rothova, P. de Vries
  • Ocul Immunol Inflamm
  • 2006
1 Excerpt

Similar Papers

Loading similar papers…